Cited 0 times in Scipus Cited Count

Central and cerebral haemodynamic changes after antihypertensive therapy in ischaemic stroke patients: A double-blind randomised trial

DC Field Value Language
dc.contributor.authorChoi, MH-
dc.contributor.authorLee, JS-
dc.contributor.authorLee, SE-
dc.contributor.authorLee, SJ-
dc.contributor.authorYoon, D-
dc.contributor.authorPark, RW-
dc.contributor.authorHong, JM-
dc.date.accessioned2019-11-13T00:17:24Z-
dc.date.available2019-11-13T00:17:24Z-
dc.date.issued2018-
dc.identifier.urihttp://repository.ajou.ac.kr/handle/201003/16665-
dc.description.abstractCentral and cerebral haemodynamic parameters can vary under similar brachial blood pressure (BP). We aimed to investigate the effects of antihypertensive agents on central and cerebral haemodynamic parameters in hypertensive patients with ischaemic stroke. The Fimasartan, Atenolol, and Valsartan On haemodynamic paRameters (FAVOR) study was conducted in a prospective, double-blinded manner. One hundred five patients were randomly administered atenolol, valsartan, or fimasartan during 12 weeks. We measured brachial, central, cerebral haemodynamic parameters and plasma N-terminal pro-brain natriuretic peptide (NT-proBNP) levels at baseline and after 12-week. Baseline haemodynamic parameters were balanced among the three groups. Even with similar brachial BP reduction, significantly lower central systolic BP (atenolol: 146.5 +/- 18.8 vs. valsartan: 133.5 +/- 20.7 vs. fimasartan: 133.6 +/- 19.8 mmHg, p = 0.017) and augmentation index values (89.8 +/- 13.2 vs. 80.6 +/- 9.2 vs. 79.2 +/- 11.6%: p = 0.001) were seen in the angiotensin receptor blockers (ARBs) groups. The pulsatility index on transcranial Doppler was significantly reduced in valsartan (p = 0.002) and fimasartan group (p = 0.008). Plasma NT-proBNP level was also significantly decreased in ARB groups, especially for the fimasartan group (37.8 +/- 50.6 vs. 29.2 +/- 36.9 vs.19.2 +/- 27.8 pg/mL: p = 0.006). These findings suggest that short-term ARB administration would be favourable for ischaemic stroke patients with hypertension, permitting effective reduction of central pressure and dampening of cerebral pulsatility.-
dc.language.isoen-
dc.subject.MESHAged-
dc.subject.MESHAntihypertensive Agents-
dc.subject.MESHAtenolol-
dc.subject.MESHBiphenyl Compounds-
dc.subject.MESHCerebrovascular Circulation-
dc.subject.MESHDouble-Blind Method-
dc.subject.MESHFemale-
dc.subject.MESHHemodynamics-
dc.subject.MESHHumans-
dc.subject.MESHHypertension-
dc.subject.MESHMale-
dc.subject.MESHMiddle Aged-
dc.subject.MESHProspective Studies-
dc.subject.MESHPyrimidines-
dc.subject.MESHStroke-
dc.subject.MESHTetrazoles-
dc.subject.MESHTreatment Outcome-
dc.subject.MESHValsartan-
dc.titleCentral and cerebral haemodynamic changes after antihypertensive therapy in ischaemic stroke patients: A double-blind randomised trial-
dc.typeArticle-
dc.identifier.pmid29367614-
dc.identifier.urlhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC5784025/-
dc.contributor.affiliatedAuthor최, 문희-
dc.contributor.affiliatedAuthor이, 진수-
dc.contributor.affiliatedAuthor이, 성준-
dc.contributor.affiliatedAuthor윤, 덕용-
dc.contributor.affiliatedAuthor박, 래웅-
dc.contributor.affiliatedAuthor홍, 지만-
dc.type.localJournal Papers-
dc.identifier.doi10.1038/s41598-018-19998-4-
dc.citation.titleScientific reports-
dc.citation.volume8-
dc.citation.number1-
dc.citation.date2018-
dc.citation.startPage1556-
dc.citation.endPage1556-
dc.identifier.bibliographicCitationScientific reports, 8(1). : 1556-1556, 2018-
dc.identifier.eissn2045-2322-
dc.relation.journalidJ020452322-
Appears in Collections:
Journal Papers > School of Medicine / Graduate School of Medicine > Neurology
Journal Papers > School of Medicine / Graduate School of Medicine > Biomedical Informatics
Files in This Item:
29367614.pdfDownload

qrcode

해당 아이템을 이메일로 공유하기 원하시면 인증을 거치시기 바랍니다.

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.

Browse